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Usher syndrome (US) is an autosomal recessive disorder characterised by retinitis pigmentosa (RP) with congenital sensorineural hearing loss. There are two clinically distinct types. Type I presents with deafness, RP, and total loss of vestibular function. In type II, the hearing loss is moderate to profound and there is no vestibular dysfunction. The clinical subtypes are consistent in families having more than one affected sib. This suggested genetic heterogeneity, where at least two different mutant genes cause the distinct phenotypes: the severe Usher type I and the milder Usher type II. Usher type II has been localised to chromosome 1q32. ' 14q, and two for type II, one localised to lq and another located somewhere else. It is reasonable to assume these genes are functionally related; some may code for similar functions or code for enzymes in a common pathway vital for normal vision and hearing. The identification and cloning of the Usher genes is necessary to discover the different role each plays.
There are two important implications with regard to these findings. First, the use of genetic markers for prenatal diagnosis of Usher type II will be confounded by heterogeneity. Although the unlinked type is relatively uncommon, a small error, equal to a value no greater than the fraction of unlinked families, will be associated with linkage based predictions. The problem will not be overcome until the specific genes and mutations associated with Usher syndrome are identified. Second, the process of pinpointing the precise segment containing the USH2a gene depends on observation of critical crossovers 
